Evidence map›Paper›PMID 42682069›Full record

ReviewThe Canadian journal of urology2026

Primary malignant melanoma of the female urethra: a case report and literature review.

Jianlin Xie, Qingwei Zhang, Jingde Wu, Yingjun Ma, Yujie Yan, Xiande Huang

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianlin Xie *The First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
Qingwei Zhang *The First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
Jingde WuThe First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
Yingjun MaDepartment of Urology, Gannan Prefecture People's Hospital, Hezuo, China.
Yujie YanDepartment of Urology, Gannan Prefecture People's Hospital, Hezuo, China.
Xiande HuangDepartment of Urology, Gansu Provincial People's Hospital, Lanzhou, China.

Funding

Clinical Application Study of Transvaginal Pelvic-Floor Biomechanical Reconstruction HX-62000001-2023-021Senile Urinary and Fecal Incontinence 2023YFC3606003
6 · The paper itself

Abstract

backgroundPrimary urethral malignant melanoma is an extremely rare malignancy of mucosal origin. Its clinical manifestations are non-specific, often leading to misdiagnosis or delayed diagnosis. Due to its highly aggressive nature and propensity for early metastasis, patient prognosis is generally poor. CASE DESCRIPTION: This case report describes an 81-year-old Chinese female patient who presented to the Department of Urology at Gansu Provincial Hospital with the chief complaint of "a black mass at the external urethral meatus accompanied by urinary incontinence for two months. Physical examination revealed a dark, protruding mass at the external urethral orifice. Imaging studies showed no evidence of distant metastasis. The patient underwent a "Radical Resection of Urethral Mass." Due to significant urethral shortening following tumor resection, a concurrent "retropubic urethropexy" was performed to preserve postoperative urinary continence. Postoperative pathology and immunohistochemistry confirmed the diagnosis of malignant melanoma. The patient declined adjuvant targeted therapy postoperatively. Short-term follow-up indicated no tumor recurrence, with satisfactory recovery of urinary function.

conclusionsFor primary urethral malignant melanoma, radical surgical resection remains the primary treatment modality. In this case, the combination of radical surgery with a concurrent urethropexy procedure achieved complete tumor removal while effectively preventing postoperative urinary incontinence resulting from local anatomical disruption. This approach highlights the importance of individualized, multifunction-preserving treatment strategies for such rare cases. Enhancing clinical awareness of this disease is crucial for facilitating early diagnosis and improving patient prognosis.

Indexed as

MelanomaUrethral NeoplasmsAged, 80 and overFemaleHumansUrethracase reportfemale urethral cancerMalignant melanomaurethral orifice

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.